Share This Article:
Review Paper

JC virus: A brief review

Full-Text HTML XML Download Download as PDF (Size:102KB) PP. 126-130
DOI: 10.4236/wjns.2013.32015    7,844 Downloads   14,567 Views   Citations

ABSTRACT

Proportional to the growth rate of its clinical expression, the last decades have seen an increase on JC Virus diagnosis testing, and on therapeutic and symptoms management plans. Whether isolated or associated to retroviral therapy, the relationship of JC Virus to HIV allowed us to delve a little deeper into the knowledge of its behavior. Now as new immune-modulating and immune-suppressing therapies are developed, its clinical expression has become broader and more complexly, thereby our need is to develop more precise diagnosis and therapeutic plans.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Ramírez, B. and Palacio, V. (2013) JC virus: A brief review. World Journal of Neuroscience, 3, 126-130. doi: 10.4236/wjns.2013.32015.

References

[1] Padgett, B.L. and Walker, D.L. (1973) Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal Leucoencephalopathy. The Journal of Infectious Diseases, 127, 467-470. doi:10.1093/infdis/127.4.467
[2] Boukoum, H., Nahdi, I., Abid, N., Foulongne, V., Sahtout, W., Zallema, D., Skiri, H., Aloui, S., Achour, A., Segondy, M. and Aouni, M. (2012) Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011. Journal of Medical Virology, 84, 1818-1824. doi:10.1002/jmv.23385
[3] Kunitake, T., Kitamura, T., Guo, J., Taguchi, F., Kawabe, K. and Yogo, Y. (1995) Parent-to-child transmission is relatively common in the spread of the human polyomavirus JC virus. Journal of Clinical Microbiology, 33, 1448-1451
[4] Agostini, H.T., Ryschkewitsch, C.F. and Stoner, G.L. (1996) Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. Journal of Clinical Microbiology, 34, 159-164.
[5] Kitamura, T., Aso, Y., Kuniyoshi, N., et al. (1990) High incidence of urinary JC virus excretion in nonimmuno-suppressed older patients. The Journal of Infectious Diseases, 161, 1128-1133. doi:10.1093/infdis/161.6.1128
[6] Sugimoto, C., Kitamura, T., Guo J., Al-Ahdal, M.N., Shchelkunov, S.N., Otova, B., Ondrejka, P., Chollet, J.Y., El-Safi, S., Ettayebi, M., Gresenguet, G., Kocagoz, T., Chaiyarasamee, S., Thant, K.Z., Thein, S., Moe, K., Ko-bayashi, N., Taguchi, F. and Yogo, Y. (1997) Typing of urinary JC virus DNA offers a novel means of tracing human migrations. Proceedings of the National Academy of Sciences of the United States, 94, 9191-9196. doi:10.1073/pnas.94.17.9191
[7] Padgett, B.L., Walker, D.L., ZuRhein, G.M., et al. (1971) Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet, 29, 1257-1260. doi:10.1016/S0140-6736(71)91777-6
[8] Khalili, K., Krynska, B., Del Valle, L., Katsetos, C. and Croul, S. (1999) Medullobas, toma and the human neurotropic polyomavirus JC virus. Lancet, 353, 1152-1153. doi:10.1016/S0140-6736(99)00357-8
[9] Krynska, B., Del Valle, L., Croul, S., Gordon, J., Katsetos, C.D., Carbone, M., Giordano, A. and Khalili, K. (1999) Detection of human neurotropic JC virus DNAsequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proceedings of the National Academy of Sciences of the United States, 96, 11519-11524. doi:10.1073/pnas.96.20.11519
[10] Del Valle, L., Azizi, S.A., Krynska, B., Enam, S., Croul, S.E. and Khalili, K. (2000) Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastomamultiforme. Annals of Neurology, 48, 932-936. doi:10.1002/1531-8249(200012)48:6<932::AID-ANA15>3.0.CO;2-E
[11] Astrom, K.E., Mancall, E.L. and Richardson, E.P. (1958) Progressive multifocal leukoencephalopathy: A hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain, 81, 93-111.
[12] Goldmann, C., Stolte, N., Nisslein, T., et al. (2000) Packaging of small molecules into VP1-virus-like particles of the humanpolyomavirus JC virus. Journal of Virological Methods, 90, 85-90. doi:10.1016/S0166-0934(00)00226-3
[13] Tan, C.S., Dezube, B.J., Bhargava, P., et al. (2009) Detection of JC virus DNAand proteins in the bone marrow of HIV-positive and HIV-negative patients: Implications for viral latency and neurotropic transformation. The Journal of Infectious Diseases, 199, 881-888. doi:10.1086/597117
[14] Weber, T. (2008) Progressive multifocal leukoencephalopathy. Neurologic Clinics, 26, 833-854. doi:10.1016/j.ncl.2008.03.007
[15] Elsner, C. and Dorries, K. (1998) Human polyomavirus JC control region variants in persistently infected CNS and kidney tissue. Journal of General Virology, l79, 789-799.
[16] Frisque, R.J., Bream, G.L. and Cannella, M.T. (1984) Human polyomavirus JC virus genome. Journal of Virology, 51, 458-469.
[17] Vaz, B., Cinque, P., Pickhardt, M. and Weber, T. (2000) Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. Journal of Neuro-Virology, 6, 398-409. doi:10.3109/13550280009018304
[18] Chang, D., Fung, C.Y., et al. (1997) Self-assembly of the JC virus major capsid protein, VP1, expressed in insect cells. Journal of General Virology, 78, 1435-1439.
[19] Sariyer, I.K., Khalili, K. and Safak, M. (2008) Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: Inhibition by small t antigen. Virology, 375, 464-479. doi:10.1016/j.virol.2008.02.020
[20] Atwood, W.J., Amemiya, K., Traub, R., Harms, J. and Major, E.O. (1992) Interaction of the human polyomavirus, JCV, with human Blymphocytes. Virology, 190, 716-723. doi:10.1016/0042-6822(92)90909-9
[21] Edeling, M.A., Smith, C. and Owen, D. (2007) Life of a clathrin coat: Insights from clathrin and AP structures. Nature Reviews. Molecular Cell Biology, 7, 32-44.
[22] Akan, I., Sariyer, I.K., Biffi, R., Palermo, V., Woolridge, S., White, M.K., Amini, S., Khalili, K. and Safak, M. (2006) Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology, 349, 66-78. doi:10.1016/j.virol.2006.01.025
[23] Frisque, R.J., Hofstetter, C. and Tyagarajan, S.K. (2006) Transforming activities of JC virus early proteins. Advances in Experimental Medicine and Biology, 577, 288-309. doi:10.1007/0-387-32957-9_21
[24] Suzuki, T., Semba, S., Sunden, Y., Orba, Y., Kobayashi, S., Nagashima, K., Kimura, T., Hasegawa, H. and Sawa, H. (2012) Role of JC virus agnoprotein in virion formation. Microbiology and Immunology, 56, 639-646. doi:10.1111/j.1348-0421.2012.00484.x
[25] Johnson, R.T. and Major, E.O. (2004) Infectious demyelinating diseases. In: Lazzarini, R., Ed., Myelin Biology and Disorders, Vol. 2. Elsevier Academic Press, Waltham, 953-983.
[26] Brew, B.J., Davies, N.W., Cinque, P., et al. (2010) Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nature Reviews Neurology, 6, 667-679. doi:10.1038/nrneurol.2010.164
[27] Tan, K., Roda, R., Ostrow, L., et al. (2009) PMl-IRIS in patients with HIV infection. Neurology, 72, 1458-1464. doi:10.1212/01.wnl.0000343510.08643.74
[28] Cinque, P., Bossolasco, A.S., Brambilla, A.M., et al. (2003) The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: Study of 43 cases with review of the literature. Journal for Neurovirology, 9, 1-8.
[29] Linda, H., von Heijne, A., Major, E.O., Ryschkewitsch, C., Berg, J., Olsson, T., et al. (2009) Progressive multifocal leukoencephalopathy after natalizumabmonotherapy. The New England Journal of Medicine, 361, 1081-1087. doi:10.1056/NEJMoa0810316
[30] Wenning, W., Haghikia, A., Laubenberger, J., Clifford, D.B., Behrens, P.F., Chan, A., et al. (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. The New England Journal of Medicine, 361, 1075-1080. doi:10.1056/NEJMoa0810257
[31] Berger, J. (2010) Progressive Multifocal Leukoencephalopathy and Newer Biological Agents. Drug Safety, 33, 969-983. doi:10.2165/11537510-000000000-00000
[32] Koralnik, I., Wüthrich, C., Dang, X., Rottnek, M., Gurtman, A., Simpson, D., et al. (2005) JC Virus Granule Cell Neuropathy: A Novel Clinical Síndrome Distinct from Progreesive Multifocal Leukoencephalopathy. Annals of Neurology, 57, 576-580. doi:10.1002/ana.20431
[33] Viallard, J.F., Ellie, E., Lazaro, E., et al. (2005) JC virus meningitis in a patient with systemic lupus erythematosus. Lupus, 14, 964-966. doi:10.1191/0961203305lu2229cr
[34] Tan, C.S. and Koralnik, I.J. (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: Clinical features and pathogenesis. The Lancet Neurology, 9, 425-437. doi:10.1016/S1474-4422(10)70040-5
[35] Marzocchetti, A., Di Giambenedetto, S., Cingolani, A., et al. (2005) Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potentantiretroviral therapy. Journal of Clinical Microbiology, 43, 4175-4177. doi:10.1128/JCM.43.8.4175-4177.2005
[36] Skolasky, R.L., Dal Pan, G.J., Olivi, A., et al. (1999) HIV-associated primary CNS morbidityand utility of brain biopsy. Journal of the Neurological Sciences, 163, 32-38. doi:10.1016/S0022-510X(98)00315-3
[37] Richardson Jr., E.P. (1961) Progressive multifocal leukoencephalopathy. The New England Journal of Medicine, 265, 815-823. doi:10.1056/NEJM196110262651701
[38] Roux, D., Bouldouyre, M.A., Mercier-Delarue, S., Seilhean, D., Zagdanski, A.M., Delaugerre, C., Simon, F., Molina, J.M. and Legoff, J. (2011) JC virus variant associated with cerebellar atrophy in a patient with AIDS. Journal of Clinical Microbiology, 49, 2196-2199. doi:10.1128/JCM.02057-10
[39] Tallantyre, E.C., Paine, S.M., Sharp, C.P., Lowe, J.S., Gran, B. (2009) Atypical progressive multifocal leukoencephalopathy associated with an unusual JC polyomavirus mutation. JAMA Neurology, 66, 1021-1024. doi:10.1001/archneurol.2009.94
[40] Huang, D., Cossoy, M., Li, M., et al. (2007) Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients. Annals of Neurology, 62, 34-39. doi:10.1002/ana.21085
[41] Tan, C.S., Ellis, L.C., Wüthrich, C., et al. (2010) JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. Journal of Virology, 84, 9200-9209. doi:10.1128/JVI.00609-10
[42] Port, J.D., Miseljic, S., Lee, R.R., et al. (1999) Progressive multifocal leukoencephalopathy demonstrating contrast enhancement on MRI and uptake of thallium-201: A case report. Neuroradiology, 41, 895-898. doi:10.1007/s002340050862
[43] Takeda, S., Yamazaki, K., Miyakawa, T., et al. (2009) Progressive multifocal leukoencephalopathy showing extensive spinal cord involvement in a patient with lymphocytopenia. Neuropathology, 29, 485-493. zdoi:10.1111/j.1440-1789.2008.00981.x
[44] Sarrazin, J.L., Soulié, D., Derosier, C., Lescop, J., Schill, H. and Cordoliani, Y.S. (1995) MRI aspects of progressive multifocal leukoencephalopathy. Journal of Neuroradiology, 22, 172-179.
[45] Bourekas, E.C., Varakis, K., Bruns, D., Christoforidis, G.A., Baujan, M., Slone, H.W. and Kehagias, D. (2002) Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. American Journal of Roentgenology, 179, 251-257. doi:10.2214/ajr.179.1.1790251
[46] Trotot, P.M., Vazeux, R., Yamashita, H.K., et al. (1990) MRI pattern of progressive multifocal leukoencephalopathy (PML) in AIDS: Pathological correlations. Journal of Neuroradiology, 17, 233-254.
[47] Sweeney, B.J., Manji, H., Miller, R.F., et al. (1994) Cortical and subcortical JC virus infection: Two unusual cases of AIDS associated progressive multifocal leukoencephalopathy. Journal of Neurology, Neurosurgery & Psychiatry, 57, 994-997. doi:10.1136/jnnp.57.8.994
[48] Menon, D.K., Ainsworth, J.G., Cox, I.J., et al. (1992) Proton MR spectroscopy of the brain in AIDS dementia complex. Journal of Computer Assisted Tomography, 16, 538-542. doi:10.1097/00004728-199207000-00007
[49] Arvik, J.G., Lenkinski, R.E., Grossman, R.I., et al. (1993) Proton MR spectroscopy of HIV infected patients: Characterization of abnormalities with imaging and clinical correlation. Radiology, 186, 739-744.
[50] Manji, H. and Miller, R.F. (2000) Progressive multifocal leucoencephalopathy: Progress in the AIDS era. Journal of Neurology, Neurosurgery & Psychiatry, 69, 569-571. doi:10.1136/jnnp.69.5.569
[51] Fontoura, P., Vale, J., Lima, C., Scaravilli, F. and Guimaraes, J. (2002) Progressive myoclonic ataxia and JC virus encephalitis in an AIDS patient. Journal of Neurology, Neurosurgery & Psychiatry, 72, 653-656. doi:10.1136/jnnp.72.5.653
[52] Adachi, E., Koibuchi, T., Imai, K., Kikuchi, T., Koga, M., Nakamura, H., Miura, T., Iwamoto, A. and Fujii, T. (2012) Favourable outcome of progressive multifocal leukoencephalopathy with mefloquine treatment in combination with antiretroviral therapy in an HIV-infected patient. International Journal of STD & AIDS, 23, 603-605. doi:10.1258/ijsa.2012.011305
[53] De Luca, A., Ammassari, A., Pezzotti, P., et al. (2008) Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: A multicohort analysis. AIDS, 22, 1759-1767. doi:10.1097/QAD.0b013e32830a5043
[54] Verma, S., Cikurel, K., Koralnik, I.J., et al. (2007) Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. The Journal of Infectious Diseases, 196, 709-711. doi:10.1086/520514
[55] Huang, S.S., Skolasky, R.L. and Dal Pan, G.J. (1998) Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: An observational study. Journal of Neuroradiology, 4, 324-332. doi:10.3109/13550289809114533
[56] Hall, C.D., Dafni, U., Simpson, D., et al. (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. The New England Journal of Medicine, 338, 1345-1351. doi:10.1056/NEJM199805073381903
[57] Gasnault, J., Hendel Chavez, E., et al. (2007) Acceleration of immune recovery on intensified ART improves survival in patients with AIDS-related PML: Preliminary reports of the ANRS 125 Trial. 14th Conference on Retroviruses and Opportunistic Illnesses, Los Angeles.
[58] Clifford, D.B., Yiannoutsos, C., Glicksman, M., et al. (1999) HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology, 52, 623-625. doi:10.1212/WNL.52.3.623
[59] Wenning, W., Haghikia, A., Laubenberger, J., Clifford, D.B., Behrens, P.F., Chan, A. and Gold, R. (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. The New England Journal of Medicine, 361, 1075-1080. doi:10.1056/NEJMoa0810257

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.